BNP Paribas Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$167M Buy
345,575
+102,032
+42% +$27.1M 0.17% 120
2026
Q1
$26.7M Buy
243,543
+57,214
+31% +$8.15M 0.03% 489
2025
Q4
$31M Buy
186,329
+185,015
+14,080% +$31M 0.04% 430
2025
Q3
$257K Buy
1,314
+11
+0.8% +$1.81K ﹤0.01% 756
2025
Q2
$118K Buy
+1,303
New +$103K ﹤0.01% 903

Other funds holding ALAB

BNP Paribas Asset Management's ALAB Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Astera Labs (ALAB) stake by 42% in Q2 2026, buying an estimated $27.1M and bringing the position to 345,575 shares worth $167M. The position accounts for 0.17% of the portfolio, ranked #120.

BNP Paribas Asset Management first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • BNP Paribas Asset Management held 345,575 shares of Astera Labs worth $167M as of Q2 2026.
  • BNP Paribas Asset Management bought 102,032 Astera Labs shares in Q2 2026, an estimated $27.1M.
  • Astera Labs made up 0.17% of BNP Paribas Asset Management's portfolio in Q2 2026, its #120 holding.
  • BNP Paribas Asset Management first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.